Zobrazeno 1 - 10
of 11
pro vyhledávání: '"J V, Fahy"'
Autor:
M. E. Lachowicz-Scroggins, W. E. Finkbeiner, E. D. Gordon, S. Yuan, L. Zlock, N. R. Bhakta, P. G. Woodruff, J. V. Fahy, H. A. Boushey
Publikováno v:
Clinical & Experimental Allergy. 47:i-i
Autor:
K W, McGrath, J V, Fahy
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 41(1)
The frequency of adults reporting a history of asthma is rising. However, it is unclear whether this increased prevalence accurately demonstrates a rising trend or if it reflects an overall increase in asthma awareness.To determine the frequency of n
Publikováno v:
Pediatric Pulmonology
Autor:
C L, Ordoñez, J V, Fahy
Publikováno v:
American journal of respiratory and critical care medicine. 164(10 Pt 1)
Autor:
R F, Lemanske, C A, Sorkness, E A, Mauger, S C, Lazarus, H A, Boushey, J V, Fahy, J M, Drazen, V M, Chinchilli, T, Craig, J E, Fish, J G, Ford, E, Israel, M, Kraft, R J, Martin, S A, Nachman, S P, Peters, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Inhaled long-acting beta(2)-agonists improve asthma control when added to inhaled corticosteroid (ICS) therapy.To determine whether ICS therapy can be reduced or eliminated in patients with persistent asthma after adding a long-acting beta(2)-agonist
Autor:
S C, Lazarus, H A, Boushey, J V, Fahy, V M, Chinchilli, R F, Lemanske, C A, Sorkness, M, Kraft, J E, Fish, S P, Peters, T, Craig, J M, Drazen, J G, Ford, E, Israel, R J, Martin, E A, Mauger, S A, Nachman, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Long-acting beta(2)-agonists are prescribed for patients with persistent asthma and are sometimes used without inhaled corticosteroids (ICSs). No evidence exists, however, to support their use as monotherapy in adults with persistent asthma.To examin
Autor:
E, Israel, J M, Drazen, S B, Liggett, H A, Boushey, R M, Cherniack, V M, Chinchilli, D M, Cooper, J V, Fahy, J E, Fish, J G, Ford, M, Kraft, S, Kunselman, S C, Lazarus, R F, Lemanske, R J, Martin, D E, McLean, S P, Peters, E K, Silverman, C A, Sorkness, S J, Szefler, S T, Weiss, C N, Yandava
Publikováno v:
International archives of allergy and immunology. 124(1-3)
Regular use of inhaled beta-adrenergic agonists may have adverse effects in some asthma patients. Polymorphisms of the beta(2)-adrenergic receptor (beta(2)-AR) can affect its regulation; however, results of smaller studies of the effects of such poly
Autor:
J V, Fahy
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 30
IgE secretion by B lymphocytes defines the allergic state and nearly all asthmatics have higher than normal IgE levels in serum following adjustment for age and sex. It is thought that allergic mechanisms may be responsible for the increasing prevale
Publikováno v:
The European respiratory journal. Supplement. 26
Autor:
J E, Fish, S P, Peters, C V, Chambers, S J, McGeady, K R, Epstein, H A, Boushey, R M, Cherniack, V M, Chinchilli, J M, Drazen, J V, Fahy, S S, Hurd, E, Israel, S C, Lazarus, R F, Lemanske, R J, Martin, E A, Mauger, C, Sorkness, S J, Szefler
Publikováno v:
American journal of respiratory and critical care medicine. 156(4 Pt 1)
Colchicine demonstrates an array of anti-inflammatory properties of potential relevance to asthma. However, the efficacy of colchicine as an alternative to inhaled corticosteroid therapy for asthma is unknown. Five centers participated in a controlle